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RESEARCH ARTICLE Open Access
Effect of an herbal/botanical supplement on
recovery from delayed onset muscle soreness: a
randomized placebo-controlled trial
Corey A Rynders2, Judy Y Weltman1, Sara D Rynders3, James Patrie1, John McKnight1, Frank I Katch1, Jay Hertel1
and Arthur Weltman1*
Abstract
Background: We examined the effects of a proprietary herbal/botanical supplement (StemSport, Stemtech, San
Clemente, CA.) suggested to increase circulating stem cells, decrease inflammation, and attenuate exercise induced
muscle damage on recovery from delayed onset muscle soreness (DOMS).
Methods: Sixteen subjects (male = 7, female = 9; age 23.8 ± 10 years; height 171.9 ± 10 cm, mass 72.2 ± 15 kg) were
randomized in a crossover, double-blind, placebo controlled trial to receive a placebo or StemSport supplement
(6150 mg/day) for 14 days. DOMS was induced on day 7 for both placebo and active conditions in the non-dominant
elbow flexor group with repeated eccentric repetitions. Muscle swelling (biceps girth), elbow flexor isometric strength
(hand held dynamometer), muscle pain/tenderness (visual analog scale), range of motion (active elbow flexion and
extension), and inflammation (hsCRP, IL6, and TNF-α) were measured at baseline and at 24 h, 48 h, 72 h, and 168 h
(1 week) post eccentric exercise. The crossover washout period was ≥14 days.
Results: No significant condition-by-time interactions between placebo and StemSport supplementation were
observed with regard to measures of pain (p = 0.59), tenderness (p = 0.71), isometric strength (p = 0.32), elbow flexion
(p = 0.45), muscle swelling (p = 0.90), or inflammation (p > 0.90). Decrements in elbow extension range of motion
48 h post-exercise were less after StemSport supplementation (Δ elbow extension 48 h post; StemSport, −2.0 deg;
placebo, −10 deg; p = 0.003).
Conclusions: These data suggest that compared to placebo, StemSport supplementation does not improve outcome
measures related to muscle recovery after acute upper-arm induced DOMS.
Keywords: DOMS, Blue-green algae, Eccentric exercise
Background
Delayed onset muscle soreness (DOMS) occurs follow-
ing a bout of unaccustomed exercise in both novice and
experienced athletes. DOMS is associated with muscle
pain, decreased range of motion, muscle fiber disruption,
altered joint kinematics, decreased strength, and acute
tissue damage; each of which contribute to an impair-
ment in future athletic performance and/or predispose
individuals to injury [1,2]. Activities that involve high
force eccentric muscle loading (e.g. plyometric exercises,
the lowering phase of resistance training, and downhill
running) induce the most severe cases of muscle dam-
age. Symptoms of diffuse pain and tenderness associated
with DOMS typically subside within 5 to 7 days after the
inciting event. As such, studies evaluating the time
course of DOMS typically include post-exercise data col-
lection intervals as long as 168-h (1-wk) into the recov-
ery period.
Delayed onset muscle soreness is a multi-factorial process
and potential mechanistic theories include both ana-
tomical/physiological and biochemical components. For
example, anatomical/physiological mechanisms include
connective tissue damage and muscular micro-trauma,
and biochemical mechanisms include inflammation, and
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oxidative stress. Acute elevations in perceived pain and
tenderness are the result of nociceptor stimulation in
damaged muscle fibers and surrounding connective tis-
sue [3]. Chronic symptoms of pain and tenderness are
likely due to increased intramuscular pressure from the
local pro-inflammatory response (e.g. IL-1β, hsIL-6,
TNF-α, hsCRP, and others) which peaks in the early
phase of recovery and typically persists for 5–7 days
after eccentric exercise [3-5].
Therapeutic modalities for the management of DOMS
related symptoms are numerous and include cryotherapy,
stretching, massage, compression, ultrasound, oral non-
steroidal anti-inflammatory drugs (NSAIDS), and exercise
[2]. In addition, several dietary supplements have been
tested (e.g. protein powders, vitamin C, fish oil, and
chondroitin sulfate) with varying success (see review by
Connolly et al. [6]). The present placebo-controlled
study examined the effects of a proprietary supplement,
StemSport (StemSport, Stemtech, San Clemente, CA.),
on the severity and time course of DOMS following
acute eccentric upper arm exercise. StemSport contains
an extract from the botanical Aphanizomenon flos-
aquae (AFA; blue-green algae), which has recently been
shown to elevate human bone marrow derived stem
cells [7]. Jensen et al. reported that a novel compound
from AFA binds to the ligand-binding area of human
L-selectin. L-selectin appears to play a role in cell adhe-
sion and the release of bone marrow stem cells into the
circulation [7]. Drapeau et al. recently hypothesized
that bone marrow-derived stem cells may accelerate the
tissue regeneration process in some animal models of
injury and may play a role in recovery from muscle
damaging exercise [8].
StemSport also contains a proprietary blend of herbal an-
tioxidants, and anti-inflammatory substances (Table 1). Pre-
liminary data suggest that supplementation with StemSport
may accelerate tissue repair and restore muscle function
earlier than would occur otherwise [7]. The manufacturer
of StemSport claims that “by assisting in increasing the
number of adult stem cells in the bloodstream the Stem-
Sport concept may help your body naturally repair, rebuild
and recover faster, so you can return to activity and athletic
participation more quickly” [9].
Many commercially available supplements are often pro-
moted without conclusive research demonstrating their ef-
ficacy. This present randomized, placebo-controlled, cross-
over study examined the effects of StemSport supplemen-
tation on the inflammatory response, muscle function, and
perceptions of pain and tenderness associated with upper
arm delayed onset muscle soreness (DOMS). We hypothe-
sized that compared to placebo, StemSport would acceler-
ate the rate of DOMS recovery.
Methods
Subjects
Subjects were healthy males (n = 7) and females (n = 9) be-
tween the ages 20 and 38 years. Subjects were of normal
weight (mean ± SD, Mass = 72.2 ± 14 kg; Body Fat = 24.4 ±
5%) and not currently participating in a structured resist-
ance or aerobic endurance training program (resistance
exercise was performed ≤ 30 min/day, 1 day/week and low
to moderate aerobic exercise was performed ≤ 30 min/day,
3 days/week; subjects were asked to refrain from perform-
ing high intensity exercise resistance/aerobic training for
the duration of the study). Exclusion criteria included a
history of vascular disease, pregnancy, recent injury or
surgery to their non-dominant elbow or upper arm mus-
culature, soft tissue compression complications such as
open wounds/broken skin of the non-dominant shoulder,
arm, wrist or hand, neurological impairments, such as
paresthesia or peripheral neuropathies, circulatory insuffi-
ciencies, such as diabetes, hemopheila, thrombophlebitis
or phlebothrombosis, and regular use of over-the-counter
and prescription pain and inflammation medications, or
any agent known to treat the pain and tenderness associ-
ated with DOMS. The Institutional Review Board at the
University of Virginia approved the study and subjects
provided written informed consent prior to participation.
Table 1 StemSport ingredient list and purported benefits
Ingredient Amount per serving Purported benefit
1. Aphanizomenon flos-aquae extract 1000 mg Increase the number of circulating stem cells; muscle repair [7,8]
2. Proprietary Herbal/Botanical Blend* 1575 mg
Cats Claw – Antioxidant [16]
Mangosteen – Antioxidant [17]
Rehmannia – Anti-inflammatory [18]
Berry extracts – Antioxidant
Nattokinase – Anti-inflammatory/fibrinolytic [19,20]
Serrapeptase – Anti-inflammatory/fibrinolytic [20]
Curcumin – Antioxidant/anti-inflammatory [21,22]
*Specific doses not provided by the manufacturer.
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Design
A study timeline is provided in Figure 1. Subjects were
initially examined by the study physician in the General
Clinical Research Center (GCRC) at UVA to ensure pre-
screening eligibility. Eligible subjects were given a 14 day
supply of StemSport or a placebo. Subjects and members
of the study team were blinded to the treatment condi-
tion. After 7-days of lead-in supplementation, subjects
returned to the GCRC to complete baseline tests of
upper arm swelling, range of motion, and visual analog
scales to evaluate perceptions of elbow flexor pain and
tenderness. Blood samples were obtained for analysis of
highly sensitive C-reactive protein (hsCRP), tissue necrosis
factor-alpha (TNF-α), and interleukin-6 (IL-6). After base-
line testing, subjects performed an upper-arm DOMS
exercise protocol. Tests of upper arm swelling, range of
motion, pain and tenderness visual analog scales, and
blood draws were repeated 24 h, 48 h, 72 h, and 168 h
(1 week) after the DOMS exercise protocol in each condi-
tion (StemSport/Placebo).
StemSport and placebo supplementation
The StemSport ingredient list is presented in Table 1.
Subjects were instructed to adhere to the following daily
dosing schedule according to manufacturer recommen-
dations: 1000 mg of Aphanizomenon flos-aquae extract
3 times per day in conjunction with food (breakfast,
lunch, and dinner) and 1575 mg of a proprietary herbal/
botanical blend twice per day in conjunction with food
(breakfast and dinner). Prior to the DOMS protocol sub-
jects ingested an extra 1000 mg dose of Aphanizomenon
flos-aquae and an extra 1575 mg dose of the herbal/bo-
tanical blend. The extra dose was ingested with water at
least 1-hour prior as per manufacturer instructions. No
food was ingested because the pre-DOMS blood samples
were collected in the fasted state. The placebo was visu-
ally similar to StemSport but consisted of a biologically
inactive substance (1000 mg of encapsulated corn starch).
The time of day that the supplements were taken was
standardized to meal time (e.g. breakfast, lunch, and
dinner). Subjects were required to maintain a pill diary
throughout the study and were instructed to forfeit any
capsules not ingested during the study period. Over-the-
counter analgesic and anti-inflammatory medications (i.e.
Tylenol, Advil, Ibuprofen, Motrin, Bextra, Celebrex, etc.)
were prohibited during the supplementation period.
An independent manufacturer (StemSport, Stemtech,
San Clemente, CA.) packaged and the supplements/
placebo. Supplements (placebo/active) were stored and
distributed to subjects by the University Investigational
Pharmacy. None of the members of the study team (ex-
cept the pharmacist) knew the identity of the supplements
during the study. The order of supplement consumption
(placebo or active) was randomly assigned based on a code
known only to the pharmacist and the study biostatistician.
Pain and tenderness
A pressure algometer (Wagner Instruments, Greenwich,
CT) was used to assess the pressure sensitivity and pain
tolerance of the soft-tissue 5 cm proximal to the elbow
joint line of the biceps brachii muscle. Each subject
received 0.91 kg of compression and recorded their per-
ceived level of pain on a visual analog scale (VAS) from 0–
10, 0 indicating no pain and 10 representing the worst
pain ever experienced. Perceived tenderness of the biceps
brachii was also assessed using the same visual analog
scale. A standard plastic measurement tape with 1 mm
gradations was used to measure the girth of the non-
dominant arm 5 cm proximal to the elbow joint line.
Biceps peak force
Isomeric elbow flex strength of the dominant arm was
measured at an angle of 90 degrees using a hand-held dyna-
mometer (Hoggan Health Industries, West Jordan, Utah).
Figure 1 Study timeline. Subjects were administered either active or placebo for a 7 day lead in period. After the lead-in period, baseline measures
of muscle function were assessed. Subjects then performed a standardized DOMS protocol for the upper arm. Stemsport/placebo supplementation
continued for 7 days post-DOMS. Muscle function outcome measures were repeated for 3 consecutive days after the DOMS protocol and once again
7 days after the DOMS protocol. Subjects repeated the protocol (opposite condition) after a minimum 14-day washout period.
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The test was performed in the standing position with the
subject’s upper arm resting against a wall to ensure exclu-
sive contraction of the elbow flexors.
Range of motion
A standard goniometer (Model G300, Whitehall Manu-
facturing, City of Industry, CA) was used to measure the
degrees of active elbow range of motion (extension and
flexion).
Inflammatory assays
Subjects were fasted at least 6 hours prior to the blood
draws at each time point. They were not allowed to con-
sume any food and/or drink prior to the other baseline
measurements or DOMS protocol. Water consumption
was allowed, but the intake volume was not measured.
TNF-alpha and IL-6 concentrations were measured in
serum using high-sensitivity ELISA assays. The assay
sensitivities were 0.5 pg · ml − 1 for TNF-α and 0.3 ng ·
ml − 1 for IL-6; the mean intra- and interassay coeffi-
cients of variation were 6.7% and 13.4% for TNF-α, and
7.4% and 7.8% for hsIL-6. CRP concentrations were
measured by a chemiluminescent assay (Diagnostic
Products Corporation, Immulite 2000, Los Angeles, CA),
the assay sensitivity was 0.1 mg · l − 1 and the mean
intra- and interassay coefficients of variation were 6.7%.
DOMS
After completion of the baseline tests above, subjects
performed an upper arm DOMS protocol as described
by Denegar et al. [10]. Proper positioning, timing, and
form for the DOMs protocol were thoroughly explained
by the study team and subjects were allowed to practice
the protocol with light weights prior to the first supple-
mentation period/actual day of testing. DOMS protocol
prior to actually performing it. A preacher curl bench
with adjustable height was used to isolate the biceps bra-
chii muscle group of the non-dominant arm. Subjects
repetitively performed all eccentric contractions, while
study personnel performed the concentric phase of the
bicep curl. The DOMS protocol was designed to be per-
formed with continuous repetitions until exhaustion (i.e.
there was not a prescription of sets and repetitions and
there was no allotted rest interval within the protocol).
Each subject started with a 15.91 kg dumbbell and per-
formed eccentric contractions until unable to lower the
weight under control over a three second count (if un-
able to perform one successful repetition with a 15.91 kg
weight, subjects began with a 13.63 kg weight). The
weight decreased in 2.27 kg (5 lbs) increments after a
participant could no longer complete repetitions at a
given weight all the way down to a final weight of
2.27 kg (5 lbs). The DOMS protocol was complete once
the subject was unable to lower a 2.27 kg weight under
control. Verbal cues were provided throughout the fa-
tigue protocol, including encouragement to exert full
strength and reminders about the minimum three sec-
ond count. Upon completion of the DOMS protocol,
each subject was provided with an arm sling to secure
the non-dominant arm against the body with the elbow
flexed at 90°. Subjects were asked to wear the sling up to
the start of day 3 (72-hours post-DOMS exercise) and
remove it only to perform activities of daily living (i.e.
bathing, getting dressed, sleeping, driving).
Follow-up measures
Measures of pain and tenderness, muscle function, and
blood draws for inflammatory markers were repeated 24-
hours, 48-hours, 72-hours, and 168-hours (1-week) fol-
lowing DOMS protocol. After the 1-week post-exercise
visit, subjects completed a 14-day washout period and
then repeated the protocol exactly as outlined above with
opposite treatment condition (StemSport or Placebo).
Subjects were asked to maintain similar dietary patterns
throughout the duration of the study.
Statistical analyses
Separate RM-ANOVA models were used to evaluate the
effects of StemSport versus placebo on the primary out-
comes. The primary outcome measures were change in
perceived pain and tenderness (VAS scales), change in
edema (girth), change in muscle function (range of mo-
tion and biceps peak force), and change in inflammation
(hsCRP, TNF-alpha, and IL-6) 24-hours, 48-hours, 72-
hours, and 168-hours post-DOMS. Treatment status
(StemSport or placebo) was the between group factor and
time was the within group factor. Baseline (pre-DOMS)
values were used as covariates. Comparisons between con-
ditions were tested by way of a Bonferoni adjusted linear
contrast of means. A p ≤ 0.05 decision rule was utilized as
the null hypothesis rejection criterion for the individual ad-
justed statistical tests. SAS version 9.2 (SAS Institute Inc,
Cary, NC, USA) was used to conduct the data analyses.
Results
Safety
There were no serious adverse events during the study
period. Subjects reported unusual urine oder (n = 1),
tiredness (n = 1), dry mouth (n = 1), headaches (n = 2),
and nausea (n = 1) while on StemSport supplementation
and tiredness/headaches (n = 1) while on the placebo.
There were no subject dropouts.
Pain and tenderness
Perceived ratings of muscle pain and tenderness were
significantly increased in both conditions for 72 hours
post-exercise (p < 0.001; Figure 2A and B). There were
no differences in pain or tenderness ratings between
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conditions at any time point (baseline adjusted comparison
of the mean change in pain and tenderness at 24, 48, 72,
and 168 hours post-exercise, p = 0.99). Biceps girth, a meas-
ure of local tissue swelling, was increased for 48-hours
post-exercise in both conditions (p < 0.03; Figure 2C).
Measures of muscle function
Biceps peak force was decreased for 72 hours in both
the placebo (p < 0.02; Figure 3A) and StemSport condi-
tion (p < 0.05; Figure 3A). Significant decrements in
elbow extension range of motion were observed for
72 hours during the placebo (p < 0.001; Figure 3B), and
range of motion tended to be reduced during StemSport
supplementation (p < 0.14; Figure 3B). Elbow flexion
range of motion was significantly reduced in both
groups for 72 hours (p < 0.03; Figure 3C). The only sig-
nificant difference in muscle function between condi-
tions was elbow extension range of motion (placebo, 10
degree decrement in elbow extension range of motion at
48 hours post-exercise versus StemSport, 2 degree dec-
rement in elbow extension range of motion; p = 0.003;
Figure 3B). Overall, less extension range of motion dec-
rement post-exercise was found with supplementation of
StemSport versus the placebo up to 72-hrs post exercise.
All measures of muscle function returned to baseline




Figure 2 Baseline adjusted comparison of the mean change (±SEM) in (A) elbow flexor pain and (B) tenderness, and (C) biceps girth
between StemSport and placebo at 24, 48, 72 and 168 hours post-DOMS exercise. *Perceived ratings of muscle pain and tenderness were
significantly increased in both conditions for 72 hours post-exercise (p < 0.001; A and B).
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Inflammatory markers
Complete blood work was completed on 14 of 16 sub-
jects and the data are presented in Figure 4A-C (missing
data due to difficulties with blood draws and laboratory
analysis). Systemic markers of inflammation did not sig-
nificantly change from baseline values in either condi-
tion (hsCRP, p-value for time = 0.24; IL-6, p-value for
time = 0.05; TNF-α, p-value for time = 0.24). There were
no differences between groups for plasma markers of in-
flammation (p = 0.90).
Discussion
The main finding of the present study is that StemSport
did not accelerate recovery from an acute bout of single
upper-arm eccentric exercise in non-resistance trained
adults.
StemSport contains the fresh water blue-green algae,
AFA, which has been studied primarily for its antioxi-
dant/anti-inflammatory properties [11]. The effects of
AFA on inflammation are limited to animal studies [11].
To our knowledge, the present study is the first to exam-
ine the effects of AFA on systemic inflammation and
other markers of DOMS in humans.
Most recently, AFA has been suggested to be a poten-
tial bone marrow stem cell mobilizer [7]. Studies from
Jensen et al. (2007) and Drapeau et al. (2010) indicate
that a novel compound from AFA appears to play a role
in the release of bone marrow stem cells into the circu-
lation, and it has been suggested that bone marrow-
derived stem cells may accelerate the tissue regeneration
process in some animal models of injury [7,8]. It has




Figure 3 Baseline adjusted comparison of the mean change (±SEM) in (A) biceps peak force, (B) elbow extension range of motion, and
(C) elbow flexion range of motion between StemSport and placebo at 24, 48, 72 and 168 hours post-DOMS exercise. *p = 0.003,
significantly different from placebo. For biceps peak force, 0.91 kg equates to 2 pounds or 8.9 Newtons.
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recovery from muscle damaging exercise via increasing
bone marrow-derived stem cells, although this has not
been tested directly in humans [8].
In a placebo-controlled double-blind crossover study, a
5:1 concentrate of AFA concentrate fed to healthy volun-
teers (n = 12) produced a 25 ± 1% increase in number of
circulating CD34+ stem cells at 60 minutes (p < 0.0001)
[7]. In contrast, the placebo only produced minor fluctua-
tions in levels of stem cells in the blood circulation over
2 hours. It has been hypothesized that acute increases in
post-exercise circulating levels of stem cells may be bene-
ficial for tissue regeneration and recovery [8]. Stem cell
counts (e.g. CD34+) were not specifically measured in the
present study, however, given that recovery of muscle
function was similar between conditions, it is unlikely that
any AFA induced change in circulating stem cells plays a
major role in recovery from upper arm DOMS.
In agreement with previous studies in the literature,
we did not observe an association between circulating
inflammatory markers and others markers of DOMS
(e.g. pain and tenderness) [12,13]. However, this may
be related to the relatively small muscle mass utilized
in our DOMS protocol which may not have been a potent
stimulus for increasing circulating cytokines. Future stud-
ies should attempt to study AFA supplementation in
response to an eccentric exercise protocol designed to
produce a much larger inflammatory response (i.e. down-
hill running).
Figure 4 Baseline adjusted comparison of the mean change (±SEM) in (A) hsCRP, (B) IL-6, and (C) TNF-α between StemSport and
placebo at 24, 48, 72 and 168 hours post-DOMS exercise.
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Leukocytes, neutrophils, and monocytes/macrophages
are attracted to damaged tissue within hours of tissue in-
jury and remain present for up to 24 hours, or as has
been shown in macrophages, up to 14 days [14]. Neutro-
phils and macrophages assist in degradation of damaged
muscle tissue primarily through production of reactive
oxygen and nitrogen species (RONS). Degradation of
damaged tissue is also initiated by the expression of
many local pro- and anti-inflammatory cytokines (e.g.
IL-6, TNF-α, IL-1β, etc.). Circulating IL-6, which has
both pro- and anti-inflammatory functions, is related to
the level of DOMS, and there is some debate as to
whether the post-exercise IL-6 response is required for
muscle adaptation [5]. Elevated levels of IL-6 persist for
at least 48 hours after eccentric upper arm exercise [15].
Less is known about the post-exercise time course of
TNF-α, although studies have detected elevated levels of
TNF-α for up to 5 days during DOMS [15]. The present
data do not support a role of AFA in suppressing circu-
lating levels of IL-6, TNF-α, or CRP in humans in the
basal state or in response to an acute bout of upper arm
eccentric exercise designed to induce DOMS.
Besides AFA, StemSport contains a proprietary blend
of several herbal substances potential antioxidant or
anti-inflammatory properties (Cat’s Claw [16], Mango-
steen juice [17], Radix Rehmanniae Preparata [18], Nat-
tokinase [19,20], Serrapeptase and [20], and Curcumin
[21]; see Table 1). For example, Curcumin, an ingredient
derived from the spice Tumeric, has been shown in a
few studies to reduce DOMS related pain and swelling
[17,22] and has a potential role is reducing obesity-
related inflammation. However, our data tend to agree
with the majority of studies in the literature which show
that oral antioxidant supplementation has minimal to no
effect on reducing subjective ratings of pain, tissue swell-
ing, or decrements in muscle function after a bout of ec-
centric exercise [2,23-25]. It should be noted that data in
the literature now support an inhibitory effect of oral anti-
oxidant supplementation on the skeletal muscle adapta-
tions exercise [26]. In addition, supplementation with the
popular antioxidant ascorbic acid has been shown to delay
the recovery process [24].
A possible limitation of this study was the use of
DOMS to examine the utility of StemSport. It is possible
that the amount of tissue damage associated with the
DOMS protocol may have been too great for StemSport
to have an effect. It is possible that if a less disruptive
regimen was applied (e.g. strength training) StemSport
supplementation may enhance chronic adaptations to
whole body resistance training. Also, future studies may
consider investigating the effects of AFA, independent or
in combination with the other herbal substances. Strengths
include study design (placebo-controlled, double-blinded,
randomized trial) and measurement of both subjective
markers of DOMS as well as bio-markers of the inflamma-
tory process.
Conclusions
Supplementation with StemSport compared to a placebo
was unable to accelerate recovery from upper arm eccen-
tric exercise. In agreement with the majority of studies in
the literature, dietary supplementation with antioxidant/
anti-inflammatory substances likely provides minimal to
no benefit for reducing the acute symptoms associated
with delayed onset muscle soreness.
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